Search details
1.
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
Cancer
; 127(16): 2954-2965, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-33951180
2.
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Biochim Biophys Acta Rev Cancer
; 1869(2): 117-127, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29360544
3.
Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer.
Mol Carcinog
; 59(1): 62-72, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31674708
4.
Racial Disparity in Response to Prostate Cancer Systemic Therapies.
Curr Oncol Rep
; 22(9): 96, 2020 07 23.
Article
in English
| MEDLINE | ID: mdl-32700096
5.
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.
Cancer Metastasis Rev
; 33(2-3): 441-68, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24414193
6.
Development of a method to isolate circulating tumor cells using mesenchymal-based capture.
Methods
; 64(2): 129-36, 2013 Dec 01.
Article
in English
| MEDLINE | ID: mdl-23845299
7.
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.
JCO Precis Oncol
; 8: e2300654, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38547422
8.
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer.
Prostate Cancer Prostatic Dis
; 2024 Apr 02.
Article
in English
| MEDLINE | ID: mdl-38565911
9.
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma.
Cancer Res Commun
; 4(2): 530-539, 2024 02 26.
Article
in English
| MEDLINE | ID: mdl-38345536
10.
Genomic classifiers and prognosis of localized prostate cancer: a systematic review.
Prostate Cancer Prostatic Dis
; 2024 Jan 10.
Article
in English
| MEDLINE | ID: mdl-38200096
11.
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.
Cancer Epidemiol Biomarkers Prev
; 33(3): 419-425, 2024 03 01.
Article
in English
| MEDLINE | ID: mdl-38189661
12.
Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM Trial.
JCO Precis Oncol
; 7: e2300214, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37595184
13.
Study design and methods for the pilot study of muscadine grape extract supplement to improve fatigue among older adult cancer survivors (FOCUS) trial.
J Geriatr Oncol
; 14(4): 101478, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36990930
14.
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 26(2): 302-308, 2023 06.
Article
in English
| MEDLINE | ID: mdl-35306542
15.
Homologous Recombination Repair Gene Variants and Outcomes Among Patients With Prostate Cancer Treated With Poly (ADP-ribose) Polymerase Inhibitors.
JCO Precis Oncol
; 6: e2100461, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35476551
16.
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting.
Fed Pract
; 39(Suppl 3): S35-S41, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-36426110
17.
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.
J Immunother Cancer
; 10(8)2022 08.
Article
in English
| MEDLINE | ID: mdl-35940825
18.
Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies.
Prostate Cancer Prostatic Dis
; 24(2): 301-309, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33168966
19.
Body composition, physical function and quality of life in healthy men and across different stages of prostate cancer.
Prostate Cancer Prostatic Dis
; 24(3): 725-732, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33495569
20.
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.
Eur Urol Oncol
; 4(6): 948-954, 2021 12.
Article
in English
| MEDLINE | ID: mdl-32063492